News

A survey of caregivers finds that most experienced instances of delayed care and other stresses.

The Duke Department of Neurosurgery has been ranked fourth for neurosurgery research funding from the National Institutes of Health (NIH) for 2020.

When James H.

The finding from a genetic analysis of tumors treated with Duke’s poliovirus therapy suggests a predictive biomarker for survival

 

Neuroprotective drug may benefit patients with DCM Degenerative cervical myelopathy (DCM) is the leading cause of spinal cord dysfunction among adults worldwide.  This condition is characterized by stenosis, or compression of the cervical spinal cord and manifests in weakness and incoordination of both the upper and lower extremities.  As patients age, osteoarthritis of the facet joints and ligaments makes this compression worse.

Glioblastoma, epilepsy, scoliosis, stroke, and more: 10 highlights of the past year that you may have missed from Duke Neurosurgery and Duke Neurology.

Duke's Michael Haglund, MD, PhD, is known for many things. As a world-class neurosurgeon, he is one of the top spine surgeons in the country.

As the population of cancer survivors increases in the United States, the overall incidence of cancer metastasizing to the brain and spine is increasing as well, with an annual estimate of more tha

To make a referral to the Duke Center for Brain and Spine Metastasis, call 919-681-3038.

A new study may have solved the mystery behind why mesenchymal stem cells (MSCs) continued to suppress inflammation in the body long after the MSCs are cleared from the system.